These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11851747)

  • 1. The measurement of health-related quality of life (HRQL) in children with cerebral palsy.
    Bjornson KF; McLaughlin JF
    Eur J Neurol; 2001 Nov; 8 Suppl 5():183-93. PubMed ID: 11851747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
    Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
    Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation.
    Houltram J; Noble I; Boyd RN; Corry I; Flett P; Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():194-202. PubMed ID: 11851748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E; Trevisi E; Martinuzzi A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving access to selective dorsal rhizotomy for children with cerebral palsy.
    Davidson B; Fehlings D; Milo-Manson G; Ibrahim GM
    CMAJ; 2019 Nov; 191(44):E1205-E1206. PubMed ID: 31685663
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of the neural component of torque during manually-applied spasticity assessments in children with cerebral palsy.
    Bar-On L; Desloovere K; Molenaers G; Harlaar J; Kindt T; Aertbeliën E
    Gait Posture; 2014 Jul; 40(3):346-51. PubMed ID: 24931109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial.
    Hastings-Ison T; Blackburn C; Rawicki B; Fahey M; Simpson P; Baker R; Graham K
    Dev Med Child Neurol; 2016 Jul; 58(7):750-7. PubMed ID: 26589633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy.
    Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():30-9. PubMed ID: 11851732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
    García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL
    Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of children with ambulatory cerebral palsy: an evidence-based review.
    Narayanan UG
    J Pediatr Orthop; 2012 Sep; 32 Suppl 2():S172-81. PubMed ID: 22890458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy.
    Redman TA; Finn JC; Bremner AP; Valentine J
    J Paediatr Child Health; 2008; 44(7-8):409-14. PubMed ID: 18557810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin-A with and without rehabilitation for the treatment of spastic cerebral palsy.
    Jianjun L; Shurong J; Weihong W; Yan Z; Fanyong Z; Nanling L
    J Int Med Res; 2013 Jun; 41(3):636-41. PubMed ID: 23696596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.
    Fazzi E; Maraucci I; Torrielli S; Motta F; Lanzi G
    J Child Neurol; 2005 Aug; 20(8):661-6. PubMed ID: 16225811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
    Dubinsky RM
    Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.